Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric proton pump to lower acid production, making it useful for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: reduces acid exposure to allow ulcer healing. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients requiring long‑term NSAID therapy.

Pantoprazole is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional, may improve with food. - Abdominal pain: mild discomfort. - Flatulence: increased gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Anaphylactic reaction: signs of severe allergy such as rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmia. - Elevated liver enzymes: possible hepatic irritation. - Stevens‑Johnson syndrome: severe skin blistering. - Acute pancreatitis: sudden abdominal pain with nausea.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust use in patients with severe renal impairment. - Magnesium monitoring: check serum levels during prolonged treatment. - Hepatic impairment: use with caution in moderate to severe liver disease. - Known hypersensitivity: avoid if the patient has experienced allergic reactions to pantoprazole or other PPIs. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may alter the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy. - Nelfinavir: lowered protease inhibitor levels. - Rilpivirine: diminished HIV‑1 inhibition. - Clopidogrel: reduced antiplatelet activation.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Phenytoin: possible reduction in anticonvulsant effect. - Digoxin: altered serum concentrations. - Methotrexate: increased risk of toxicity. - Oral contraceptives: may decrease hormonal effectiveness.